{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,24]],"date-time":"2025-12-24T14:50:29Z","timestamp":1766587829969},"reference-count":52,"publisher":"Elsevier","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2000]]},"DOI":"10.1016\/s0169-7161(00)18035-6","type":"book-chapter","created":{"date-parts":[[2005,4,18]],"date-time":"2005-04-18T19:58:53Z","timestamp":1113854333000},"page":"977-1002","source":"Crossref","is-referenced-by-count":2,"title":["33 Methods of establishing in vitro-in vivo relationships for modified release drug products"],"prefix":"10.1016","author":[{"given":"David T.","family":"Mauger","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vernon M.","family":"Chinchilli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/S0169-7161(00)18035-6_bib1","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1023\/A:1016212804288","article-title":"A theoretical basis for a biopharmaceutical drug classification: The correlation of in vitro drug product dissolution and in vivo bioavailability","volume":"12","author":"Amidon","year":"1995","journal-title":"Pharmaceut. Res."},{"key":"10.1016\/S0169-7161(00)18035-6_bib2","first-page":"207","article-title":"Use of nonlinear mixed effects modelling in the development of in vitro-in vivo correlations","volume":"vol. 423","author":"Bigora","year":"1997"},{"issue":"3","key":"10.1016\/S0169-7161(00)18035-6_bib3","first-page":"248","article-title":"In vitro-in vivo correlation, a time scaling problem? Basic considerations on in vitro dissolution testing","volume":"32","author":"Brockmeier","year":"1982","journal-title":"Arzneimittelforsch\/Drug Research"},{"issue":"4","key":"10.1016\/S0169-7161(00)18035-6_bib4","first-page":"598","article-title":"In vitro-in vivo correlation, a time scaling problem? Basic techniques for testing equivalence","volume":"33","author":"Brockmeier","year":"1983","journal-title":"Arzneimittelforsch\/Drug Research"},{"issue":"11","key":"10.1016\/S0169-7161(00)18035-6_bib5","first-page":"1604","article-title":"In vitro-in vivo correlation, a time scaling problem? Evaluation of mean times","volume":"34","author":"Brockmeier","year":"1984","journal-title":"Arzneimittelforsch\/Drug Research"},{"key":"10.1016\/S0169-7161(00)18035-6_bib6","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/BF00543326","article-title":"In vitro-in vivo correlation of dissolution, a time scaling problem? Transformation of in vitro results to the in vivo situation, using theophylline as a practical example","volume":"28","author":"Brockmeier","year":"1985","journal-title":"Europ. J. Clin. Pharmacol."},{"key":"10.1016\/S0169-7161(00)18035-6_bib7","first-page":"93","article-title":"Examples of developing in vitro-in vivo relationships","volume":"vol. 423","author":"Butler","year":"1997"},{"issue":"1","key":"10.1016\/S0169-7161(00)18035-6_bib8","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/BF03220014","article-title":"In vitro-in vivo correlations: Scientific implications and standardisation","volume":"18","author":"Cardot","year":"1993","journal-title":"Europ. J. Drug Metabol. Pharmacokinetics"},{"issue":"6","key":"10.1016\/S0169-7161(00)18035-6_bib9","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1002\/jps.2600760607","article-title":"Evaluation of in vivo drug release by numerical deconvolution using oral solution data as weighting function","volume":"76","author":"Chan","year":"1986","journal-title":"J. Pharmaceut. Sci."},{"key":"10.1016\/S0169-7161(00)18035-6_bib10","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/0163-7258(81)90058-9","article-title":"Assessment of rate and extent of drug absorption","volume":"14","author":"Cutler","year":"1981","journal-title":"Pharmaceut. Ther."},{"key":"10.1016\/S0169-7161(00)18035-6_bib11","first-page":"241","article-title":"Impact of IVIVR on product development","volume":"vol. 423","author":"Devane","year":"1997"},{"key":"10.1016\/S0169-7161(00)18035-6_bib12","first-page":"225","article-title":"Development of in vitro-in vivo correlations using various artificial neural network configurations","volume":"vol. 423","author":"Dowell","year":"1997"},{"issue":"2","key":"10.1016\/S0169-7161(00)18035-6_bib13","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1002\/jps.2600820204","article-title":"In vitro-in vivo correlation for modified-release formulations","volume":"82","author":"Drewe","year":"1993","journal-title":"J. Pharmaceut. Sci."},{"key":"10.1016\/S0169-7161(00)18035-6_bib14","first-page":"67","article-title":"Approaches to IVIVR modelling and statistical analysis","volume":"vol. 423","author":"Dunne","year":"1997"},{"issue":"4","key":"10.1016\/S0169-7161(00)18035-6_bib15","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/BF01061699","article-title":"Investigating relationships between in vivo and in vitro pharmacological variables for the purpose of prediction","volume":"5","author":"Fairweather","year":"1977","journal-title":"J. Pharmacokin. Biopharmaceut."},{"key":"10.1016\/S0169-7161(00)18035-6_bib16","first-page":"53","article-title":"Convolution-based approaches for in vivo-in vitro correlation modeling","volume":"vol. 423","author":"Gillespie","year":"1997"},{"key":"10.1016\/S0169-7161(00)18035-6_bib17","series-title":"Pharmacokinetics, Second Edition","author":"Gibaldi","year":"1982"},{"issue":"9","key":"10.1016\/S0169-7161(00)18035-6_bib18","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1023\/A:1016277724645","article-title":"New evaluation method for in vitro\/in vivo correlation of enteric-coated multiple unit dosage forms","volume":"12","author":"Hayashi","year":"1995","journal-title":"Pharmaceut. Res."},{"key":"10.1016\/S0169-7161(00)18035-6_bib19","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/978-1-4684-6036-0_12","article-title":"Artificial neural network based based in vitro-in vivo correlations","volume":"423","author":"Hussain","year":"1997","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/S0169-7161(00)18035-6_bib20","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1023\/A:1016355114960","article-title":"In vitro-in vivo correlations: An unrealistic problem","volume":"3","author":"H\u00fcttenrauch","year":"1985","journal-title":"Pharmacol. Res."},{"issue":"6","key":"10.1016\/S0169-7161(00)18035-6_bib21","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1248\/bpb.18.882","article-title":"A new pharmacokinetic model including in vivo dissolution and gastrointestinal transit parameters","volume":"18","author":"Ishii","year":"1995","journal-title":"Biol. Pharm. Bull."},{"issue":"8","key":"10.1016\/S0169-7161(00)18035-6_bib22","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1248\/cpb.44.1550","article-title":"Novel approach for determination of correlation between in vivo and in vitro dissolution using the optimization technique","volume":"44","author":"Ishii","year":"1996","journal-title":"Chem. Pharm. Bull."},{"issue":"11","key":"10.1016\/S0169-7161(00)18035-6_bib23","first-page":"1166","article-title":"Numerical convolution\/deconvolution as a tool for correlating in vitro with in vivo drug availability","volume":"44","author":"Langenbucher","year":"1982","journal-title":"Pharm Ind"},{"issue":"6","key":"10.1016\/S0169-7161(00)18035-6_bib24","first-page":"623","article-title":"Correlation of in vitro drug release with in vivo response kinetics","volume":"45","author":"Langenbucher","year":"1983","journal-title":"Pharm. Ind."},{"key":"10.1016\/S0169-7161(00)18035-6_bib25","series-title":"Pharmacokinetic Analysis: A Practical Approach","author":"Lee","year":"1996"},{"key":"10.1016\/S0169-7161(00)18035-6_bib26","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1023\/A:1016215827004","article-title":"Pharmacokinetics of oral extended-release dosage forms. I. Release kinetics, concentration, and absorbed fraction","volume":"12","author":"Liu","year":"1995","journal-title":"Pharmaceut. Res."},{"key":"10.1016\/S0169-7161(00)18035-6_bib27","first-page":"1499","article-title":"In vitro-in vivo relationship of oral extended-release dosage forms","volume":"13","author":"Liu","year":"1996","journal-title":"Pharmaceut. Res."},{"key":"10.1016\/S0169-7161(00)18035-6_bib28","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1002\/jps.2600570602","article-title":"New method for calculating the intrinsic absorption rate of drugs","volume":"57","author":"Loo","year":"1968","journal-title":"J. Pharmaceut. Sci."},{"issue":"3","key":"10.1016\/S0169-7161(00)18035-6_bib29","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/BF02353672","article-title":"A comparison of six deconvolution techniques","volume":"24","author":"Madden","year":"1996","journal-title":"J. Pharmacokin. Biopharmaceut."},{"key":"10.1016\/S0169-7161(00)18035-6_bib30","first-page":"261","article-title":"The role of in vitro-in vivo correlations (IVIVC) to regulatory agencies","volume":"vol. 423","author":"Malinowski","year":"1997"},{"key":"10.1016\/S0169-7161(00)18035-6_bib31","first-page":"269","article-title":"Draft guidance for industry extended-release solid oral dosage forms","volume":"vol. 423","author":"Malinowski","year":"1997"},{"issue":"4","key":"10.1016\/S0169-7161(00)18035-6_bib32","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1080\/10543409708835207","article-title":"In vitro-in vivo relationships for oral extended-release drug products","volume":"7","author":"Mauger","year":"1997","journal-title":"J. Biopharmaceut. Statist."},{"key":"10.1016\/S0169-7161(00)18035-6_bib33","first-page":"199","article-title":"Nonlinear in vitro-in vivo correlations","volume":"vol. 423","author":"Mendell-Harary","year":"1997"},{"key":"10.1016\/S0169-7161(00)18035-6_bib34","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/S0731-7085(96)01834-1","article-title":"In-vivo\/in-vitro correlation of four extended release formulations of pseudoephedrine sulfate","volume":"15","author":"Mojaverian","year":"1997","journal-title":"J. Pharmaceut. Biomed. Anal."},{"key":"10.1016\/S0169-7161(00)18035-6_bib35","series-title":"Biopharmaceutics and Clinical Pharmacokinetics, Fourth Edition","author":"Notari","year":"1987"},{"issue":"1","key":"10.1016\/S0169-7161(00)18035-6_bib36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2165\/00003088-199733010-00001","article-title":"Individual bioequivalence: New concepts in the statistical assessment of bioequivalence metrics","volume":"33","author":"Patnaik","year":"1997","journal-title":"Clin. Pharmacokin."},{"key":"10.1016\/S0169-7161(00)18035-6_bib37","first-page":"159","article-title":"Setting dissolution specifications for modified-release dosage forms","volume":"vol. 423","author":"Piscitelli","year":"1997"},{"issue":"7","key":"10.1016\/S0169-7161(00)18035-6_bib38","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1021\/js9503587","article-title":"Novel approach to the analysis of in vitro-in vivo relationships","volume":"85","author":"Polli","year":"1996","journal-title":"J. Pharmaceut. Sci."},{"issue":"1","key":"10.1016\/S0169-7161(00)18035-6_bib39","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/BF02353511","article-title":"Multiple solutions, illegal parameter values, local minima of the sums of squares, and anomalous parameter estimates in least-squares fitting of the two-compartment pharmacokinetic model with absorption","volume":"24","author":"Purves","year":"1996","journal-title":"J. Pharmacokin. Biopharmaceut."},{"key":"10.1016\/S0169-7161(00)18035-6_bib40","first-page":"1","article-title":"Example of in vitro-in vivo relationships with a diverse range of quality","volume":"vol. 423","author":"Rackley","year":"1997"},{"key":"10.1016\/S0169-7161(00)18035-6_bib41","series-title":"Applied Biopharmaceutics and Pharmacokinetics","author":"Shargel","year":"1993"},{"issue":"1","key":"10.1016\/S0169-7161(00)18035-6_bib42","first-page":"10","article-title":"Regulatory aspects of modified release dosage forms: in vitro-in vivo correlations","volume":"132","author":"Siewert","year":"1993","journal-title":"Boll. Chim. Farmaceutico."},{"issue":"1","key":"10.1016\/S0169-7161(00)18035-6_bib43","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/BF03220004","article-title":"Perspectives of in vitro dissolution tests in establishing in vitro-in vivo correlations","volume":"18","author":"Siewert","year":"1993","journal-title":"Europ. J. Drug Metabol. Pharmacokin."},{"issue":"9","key":"10.1016\/S0169-7161(00)18035-6_bib44","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1002\/jps.2600790923","article-title":"Report of the workshop on in vitro and in vivo testing and correlation for oral controlled\/modified-release dosage forms","volume":"79","author":"Skelly","year":"1990","journal-title":"J. Pharmaceut. Sci."},{"issue":"11","key":"10.1016\/S0169-7161(00)18035-6_bib45","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1002\/jps.2600781114","article-title":"Numerical stability of pharmacokinetic deconvolution algorithms","volume":"78","author":"S\u00fcverkr\u00fcp","year":"1988","journal-title":"J. Pharmaceut. Sci."},{"issue":"4","key":"10.1016\/S0169-7161(00)18035-6_bib46","first-page":"4160","article-title":"In vitro\/in vivo correlation for extended-release oral dosage forms","volume":"14","author":"USP Subcommittee on Biopharmaceutics","year":"1988","journal-title":"Pharmacopeial Forum"},{"issue":"4","key":"10.1016\/S0169-7161(00)18035-6_bib47","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1002\/jps.2600650432","article-title":"Simple transformation method for predicting plasma drug profiles from dissolution rates","volume":"65","author":"Vaughn","year":"1976","journal-title":"J. Pharmaceut. Sci."},{"key":"10.1016\/S0169-7161(00)18035-6_bib48","first-page":"43","article-title":"A general framework for non-parametric subject-specific and populations deconvolution methods for in vivo-in vitro correlation","volume":"vol. 423","author":"Verotta","year":"1997"},{"key":"10.1016\/S0169-7161(00)18035-6_bib49","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1002\/jps.2600531126","article-title":"Kinetic analysis of blood levels and urinary excretion in the absorptive phase after single doses of drug","volume":"53","author":"Wagner","year":"1964","journal-title":"J. Pharmaceut. Sci."},{"key":"10.1016\/S0169-7161(00)18035-6_bib50","series-title":"Biopharmaceutics and Relevant Pharmacokinetics","author":"Wagner","year":"1971"},{"key":"10.1016\/S0169-7161(00)18035-6_bib51","volume":"volume 423","year":"1997"},{"key":"10.1016\/S0169-7161(00)18035-6_bib52","first-page":"87","article-title":"Validation of in vitro-in vivo correlation models","volume":"Vol. 423","author":"Young","year":"1997"}],"container-title":["Handbook of Statistics","Bioenvironmental and Public Health Statistics"],"original-title":[],"deposited":{"date-parts":[[2019,1,27]],"date-time":"2019-01-27T02:57:05Z","timestamp":1548557825000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0169716100180356"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000]]},"references-count":52,"URL":"https:\/\/doi.org\/10.1016\/s0169-7161(00)18035-6","relation":{},"ISSN":["0169-7161"],"issn-type":[{"value":"0169-7161","type":"print"}],"subject":[],"published":{"date-parts":[[2000]]}}}